v3.26.3
Share-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
(In thousands)
Stock option expense$2,647 $2,830 $8,022 $8,946 
Restricted stock expense5,970 5,443 17,146 15,768 
Performance restricted stock unit expense5,457 4,643 12,506 10,515 
Total pre-tax expense$14,074 $12,916 $37,674 $35,229 
Schedule of Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Nine Months Ended
September 30, 2026		Year Ended December 31, 2025
Expected volatility20.1%22.7%
Expected term (years)5.05.0
Risk-free interest rate3.87%4.07%
Expected dividend yield0.64%0.70%
Black-Scholes-Merton fair value per stock option granted$51.29 $46.21 
Schedule of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life 		Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20251,950 $126.07 
Granted234 212.77 
Exercised(244)114.51 
Forfeited(35)186.61 
Outstanding at September 30, 20261,905 $137.09 5.9$210.8 
Exercisable at September 30, 20261,466 $119.61 5.0$187.8 
Schedule of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2025280 $173.25 
Granted144 213.99 
Vested(126)167.52 
Forfeited(26)188.19 
Non-vested restricted stock outstanding at September 30, 2026272 $196.04 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2025240 $166.06 
Granted79 212.77 
Performance assumption change 1
2 138.46 
Vested(77)138.46 
Forfeited(6)185.47 
Non-vested performance restricted stock outstanding at September 30, 2026238 $189.77 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.